Skip to main content
Top
Published in: World Journal of Surgical Oncology 1/2015

Open Access 01-12-2015 | Research

Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway

Authors: Huidong Sun, Yanchao Gao, Kemei Lu, Guimei Zhao, Xuehua Li, Zhu Li, Hong Chang

Published in: World Journal of Surgical Oncology | Issue 1/2015

Login to get access

Abstract

Background

Klotho is a discovered aging suppressor gene, and its overexpression in mice extends the life span of the animal. Recently, Klotho is also identified as a tumor suppressor gene in variety of tumors; however, the potential role and the antitumor mechanism remain unclarified in liver cancers.

Methods

RT-PCR and western blotting analysis were used to detect the expression of Klotho, β-catenin, C-myc, and Cyclin D1. MTT assay was used to detect the survival rates of HepG2 and SMMC-7721 cells. Colony formation assay was used to test the proliferation ability in Klotho transfected cells. FACS was used to detect the cell apoptosis rate in different groups.

Results

The results showed that lower expression of Klotho were found in liver cancer cell lines than the immortalized liver cell L02. Also, MTT assay results found that overexpression or recombinant Klotho administration suppressed the proliferation of liver cancer cells HepG2 and SMMC-7721. Moreover, the colony formation assay results showed that the number of colonies was significantly lower in the cells with transfection with pCMV-Klotho than the controls. Thus, functional analysis demonstrated that Klotho expression inhibited the proliferation of liver cancer cells and Klotho worked as an important antitumor gene in tumor progression. Next, the mechanism was partly clarified that Klotho expression induced cell apoptosis in HepG2 and SMMC-7721 cells, and this phenomenon was mainly involved in the Wnt/β-catenin signaling pathway. The western blotting analysis revealed that overexpression or recombinant administration of Klotho obviously decreased the expression levels of β-catenin, C-myc, and Cyclin D1 in HepG2 cells. Most importantly, the antitumor mechanism for Klotho due to that overexpression of Klotho not only decreased the endogenous β-catenin levels but also inhibited the nuclear translocation of β-catenin to delay the cell cycle progression.

Conclusions

Klotho was a tumor suppressor gene, and overexpression of Klotho suppressed the proliferation of liver cancer cells partly due to negative regulation of Wnt/β-catenin signaling pathway. So, Klotho might be used as a potential target, and the study will contribute to treatment for therapy of liver cancer patients.
Literature
1.
go back to reference Bester L, Meteling B, Boshell D, Chua TC, Morris DL. Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature. J Med Imaging Radiat Oncol. 2014;58:341–52.CrossRefPubMed Bester L, Meteling B, Boshell D, Chua TC, Morris DL. Transarterial chemoembolisation and radioembolisation for the treatment of primary liver cancer and secondary liver cancer: a review of the literature. J Med Imaging Radiat Oncol. 2014;58:341–52.CrossRefPubMed
2.
go back to reference Kudo M. Targeted therapy for liver cancer: updated review in 2012. Curr Cancer Drug Targets. 2012;12:1062–72.PubMed Kudo M. Targeted therapy for liver cancer: updated review in 2012. Curr Cancer Drug Targets. 2012;12:1062–72.PubMed
3.
go back to reference Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and liver cancer: a review. Curr Pharm Biotechnol. 2012;13:218–28.CrossRefPubMed Darvesh AS, Aggarwal BB, Bishayee A. Curcumin and liver cancer: a review. Curr Pharm Biotechnol. 2012;13:218–28.CrossRefPubMed
4.
go back to reference Zhang ZM, Zhang YM, Gao S, Yuan WP, Zhao YN, Xiang BD, et al. Treatment efficacy and prognostic factors for huge HCC based on Barcelona Clinic Liver Cancer staging. Asian Pac J Cancer Prev. 2014;15:8823–8.CrossRefPubMed Zhang ZM, Zhang YM, Gao S, Yuan WP, Zhao YN, Xiang BD, et al. Treatment efficacy and prognostic factors for huge HCC based on Barcelona Clinic Liver Cancer staging. Asian Pac J Cancer Prev. 2014;15:8823–8.CrossRefPubMed
5.
go back to reference Lee E, Xuan Mai TT, Chang Y, Ki M. Trends of liver cancer and its major risk factors in Korea. Epidemiol Health. 2015;37:e2015016.CrossRefPubMed Lee E, Xuan Mai TT, Chang Y, Ki M. Trends of liver cancer and its major risk factors in Korea. Epidemiol Health. 2015;37:e2015016.CrossRefPubMed
6.
go back to reference Borena W, Strohmaier S, Lukanova A, Bjorge T, Lindkvist B, Hallmans G, et al. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer. 2012;131:193–200.CrossRefPubMed Borena W, Strohmaier S, Lukanova A, Bjorge T, Lindkvist B, Hallmans G, et al. Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults. Int J Cancer. 2012;131:193–200.CrossRefPubMed
7.
go back to reference Persson EC, Quraishi SM, Welzel TM, Carreon JD, Gridley G, Graubard BI, et al. Risk of liver cancer among US male veterans with cirrhosis, 1969–1996. Br J Cancer. 2012;107:195–200.PubMedCentralCrossRefPubMed Persson EC, Quraishi SM, Welzel TM, Carreon JD, Gridley G, Graubard BI, et al. Risk of liver cancer among US male veterans with cirrhosis, 1969–1996. Br J Cancer. 2012;107:195–200.PubMedCentralCrossRefPubMed
8.
go back to reference Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45–51.CrossRefPubMed Kuro-o M, Matsumura Y, Aizawa H, Kawaguchi H, Suga T, Utsugi T, et al. Mutation of the mouse Klotho gene leads to a syndrome resembling ageing. Nature. 1997;390:45–51.CrossRefPubMed
9.
go back to reference Dermaku-Sopjani M, Kolgeci S, Abazi S, Sopjani M. Significance of the anti-aging protein Klotho. Mol Membr Biol. 2013;30:369–85.CrossRefPubMed Dermaku-Sopjani M, Kolgeci S, Abazi S, Sopjani M. Significance of the anti-aging protein Klotho. Mol Membr Biol. 2013;30:369–85.CrossRefPubMed
10.
go back to reference Doi S, Zou Y, Togao O, Pastor JV, John GB, Wang L, et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 2011;286:8655–65.PubMedCentralCrossRefPubMed Doi S, Zou Y, Togao O, Pastor JV, John GB, Wang L, et al. Klotho inhibits transforming growth factor-beta1 (TGF-beta1) signaling and suppresses renal fibrosis and cancer metastasis in mice. J Biol Chem. 2011;286:8655–65.PubMedCentralCrossRefPubMed
11.
go back to reference Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression. Cancer Invest. 2008;26:185–92.CrossRefPubMed Lu L, Katsaros D, Wiley A, de la Longrais IA, Puopolo M, Yu H. Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression. Cancer Invest. 2008;26:185–92.CrossRefPubMed
12.
go back to reference Xie B, Chen J, Liu B, Zhan J. Klotho acts as a tumor suppressor in cancers. Pathol Oncol Res. 2013;19:611–7.CrossRefPubMed Xie B, Chen J, Liu B, Zhan J. Klotho acts as a tumor suppressor in cancers. Pathol Oncol Res. 2013;19:611–7.CrossRefPubMed
13.
go back to reference Wang L, Wang X, Wang X, Jie P, Lu H, Zhang S, et al. Klotho is silenced through promoter hypermethylation in gastric cancer. Am J Cancer Res. 2011;1:111–9.PubMedCentralPubMed Wang L, Wang X, Wang X, Jie P, Lu H, Zhang S, et al. Klotho is silenced through promoter hypermethylation in gastric cancer. Am J Cancer Res. 2011;1:111–9.PubMedCentralPubMed
14.
go back to reference Li XX, Huang LY, Peng JJ, Liang L, Shi DB, Zheng HT, et al. Klotho suppresses growth and invasion of colon cancer cells through inhibition of IGF1R-mediated PI3K/AKT pathway. Int J Oncol. 2014;45:611–8.PubMed Li XX, Huang LY, Peng JJ, Liang L, Shi DB, Zheng HT, et al. Klotho suppresses growth and invasion of colon cancer cells through inhibition of IGF1R-mediated PI3K/AKT pathway. Int J Oncol. 2014;45:611–8.PubMed
15.
go back to reference Chang B, Kim J, Jeong D, Jeong Y, Jeon S, Jung SI, et al. Klotho inhibits the capacity of cell migration and invasion in cervical cancer. Oncol Rep. 2012;28:1022–8.PubMed Chang B, Kim J, Jeong D, Jeong Y, Jeon S, Jung SI, et al. Klotho inhibits the capacity of cell migration and invasion in cervical cancer. Oncol Rep. 2012;28:1022–8.PubMed
16.
go back to reference Pan H, Fu X, Huang W. Molecular mechanism of liver cancer. Anticancer Agents Med Chem. 2011;11:493–9.CrossRefPubMed Pan H, Fu X, Huang W. Molecular mechanism of liver cancer. Anticancer Agents Med Chem. 2011;11:493–9.CrossRefPubMed
17.
go back to reference Chuang SC, Lee YC, Hashibe M, Dai M, Zheng T, Boffetta P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19:1261–8.PubMedCentralCrossRefPubMed Chuang SC, Lee YC, Hashibe M, Dai M, Zheng T, Boffetta P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19:1261–8.PubMedCentralCrossRefPubMed
18.
go back to reference Fang JY, Wu KS, Zeng Y, Tang WR, Du PL, Xu ZX, et al. Liver cancer mortality characteristics and trends in china from 1991 to 2012. Asian Pac J Cancer Prev. 2015;16:1959–64.CrossRefPubMed Fang JY, Wu KS, Zeng Y, Tang WR, Du PL, Xu ZX, et al. Liver cancer mortality characteristics and trends in china from 1991 to 2012. Asian Pac J Cancer Prev. 2015;16:1959–64.CrossRefPubMed
20.
go back to reference Gao J, Xie L, Chen WQ, Zhang SW, Wu QJ, Yang Y, et al. Rural-urban, sex variations, and time trend of primary liver cancer incidence in China, 1988-2005. Eur J Cancer Prev. 2013;22:448–54.CrossRefPubMed Gao J, Xie L, Chen WQ, Zhang SW, Wu QJ, Yang Y, et al. Rural-urban, sex variations, and time trend of primary liver cancer incidence in China, 1988-2005. Eur J Cancer Prev. 2013;22:448–54.CrossRefPubMed
21.
go back to reference Sun Z, Chen T, Thorgeirsson SS, Zhan Q, Chen J, Park JH, et al. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis. 2013;34:1800–5.PubMedCentralCrossRefPubMed Sun Z, Chen T, Thorgeirsson SS, Zhan Q, Chen J, Park JH, et al. Dramatic reduction of liver cancer incidence in young adults: 28 year follow-up of etiological interventions in an endemic area of China. Carcinogenesis. 2013;34:1800–5.PubMedCentralCrossRefPubMed
22.
go back to reference Lojkin I, Rubinek T, Orsulik S, Schwarzmann O, Karlan B, Bose S, et al. Reduced expression and growth inhibitory activity of the aging suppressor Klotho in epithelial ovarian cancer. Cancer Lett. 2015. Lojkin I, Rubinek T, Orsulik S, Schwarzmann O, Karlan B, Bose S, et al. Reduced expression and growth inhibitory activity of the aging suppressor Klotho in epithelial ovarian cancer. Cancer Lett. 2015.
23.
go back to reference Chen B, Ma X, Liu S, Zhao W, Wu J. Inhibition of lung cancer cells growth, motility and induction of apoptosis by Klotho, a novel secreted Wnt antagonist, in a dose-dependent manner. Cancer Biol Ther. 2012;13:1221–8.PubMedCentralCrossRefPubMed Chen B, Ma X, Liu S, Zhao W, Wu J. Inhibition of lung cancer cells growth, motility and induction of apoptosis by Klotho, a novel secreted Wnt antagonist, in a dose-dependent manner. Cancer Biol Ther. 2012;13:1221–8.PubMedCentralCrossRefPubMed
24.
25.
go back to reference Usuda J, Ichinose S, Ishizumi T, Ohtani K, Inoue T, Saji H, et al. Klotho predicts good clinical outcome in patients with limited-disease small cell lung cancer who received surgery. Lung Cancer. 2011;74:332–7.CrossRefPubMed Usuda J, Ichinose S, Ishizumi T, Ohtani K, Inoue T, Saji H, et al. Klotho predicts good clinical outcome in patients with limited-disease small cell lung cancer who received surgery. Lung Cancer. 2011;74:332–7.CrossRefPubMed
Metadata
Title
Overexpression of Klotho suppresses liver cancer progression and induces cell apoptosis by negatively regulating wnt/β-catenin signaling pathway
Authors
Huidong Sun
Yanchao Gao
Kemei Lu
Guimei Zhao
Xuehua Li
Zhu Li
Hong Chang
Publication date
01-12-2015
Publisher
BioMed Central
Published in
World Journal of Surgical Oncology / Issue 1/2015
Electronic ISSN: 1477-7819
DOI
https://doi.org/10.1186/s12957-015-0717-0

Other articles of this Issue 1/2015

World Journal of Surgical Oncology 1/2015 Go to the issue